216 related articles for article (PubMed ID: 19158840)
1. Induction of autoimmunity in a bleomycin-induced murine model of experimental systemic sclerosis: an important role for CD4+ T cells.
Ishikawa H; Takeda K; Okamoto A; Matsuo S; Isobe K
J Invest Dermatol; 2009 Jul; 129(7):1688-95. PubMed ID: 19158840
[TBL] [Abstract][Full Text] [Related]
2. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
[TBL] [Abstract][Full Text] [Related]
3. IL-21 induction of CD4+ T cell differentiation into Th17 cells contributes to bleomycin-induced fibrosis in mice.
Lei L; Zhong XN; He ZY; Zhao C; Sun XJ
Cell Biol Int; 2015 Apr; 39(4):388-99. PubMed ID: 25492803
[TBL] [Abstract][Full Text] [Related]
4. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma.
Yamamoto T; Takagawa S; Katayama I; Yamazaki K; Hamazaki Y; Shinkai H; Nishioka K
J Invest Dermatol; 1999 Apr; 112(4):456-62. PubMed ID: 10201529
[TBL] [Abstract][Full Text] [Related]
5. Potential roles of interleukin-17A in the development of skin fibrosis in mice.
Okamoto Y; Hasegawa M; Matsushita T; Hamaguchi Y; Huu DL; Iwakura Y; Fujimoto M; Takehara K
Arthritis Rheum; 2012 Nov; 64(11):3726-35. PubMed ID: 22833167
[TBL] [Abstract][Full Text] [Related]
6. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A
Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
[TBL] [Abstract][Full Text] [Related]
7. Injection of bleomycin in newborn mice induces autoimmune sialitis that is transferred by CD4 T cells.
Ishikawa H; Ito S; Nishio N; Yuzawa Y; Matsuo S; Isobe K
Immunol Cell Biol; 2009; 87(4):351-8. PubMed ID: 19204734
[TBL] [Abstract][Full Text] [Related]
8. Increased bleomycin-induced skin fibrosis in mice lacking the Th1-specific transcription factor T-bet.
Lakos G; Melichian D; Wu M; Varga J
Pathobiology; 2006; 73(5):224-37. PubMed ID: 17314493
[TBL] [Abstract][Full Text] [Related]
9. The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis.
Meng M; Tan J; Chen W; Du Q; Xie B; Wang N; Zhu H; Wang K
Front Immunol; 2019; 10():1861. PubMed ID: 31481954
[TBL] [Abstract][Full Text] [Related]
10. Effects of oligoelements Se, Zn, and Mn plus Lachesis muta venom in experimental scleroderma.
Crescenti EJ; Medina VA; Sambuco LA; Cremaschi GA; Genaro AM; Cricco GP; Martín GA; Valli E; Martinel Lamas DJ; Perazzo JC; Rivera ES; Bergoc RM
Biol Trace Elem Res; 2014 Feb; 157(2):138-46. PubMed ID: 24363240
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis.
Avouac J; Fürnrohr BG; Tomcik M; Palumbo K; Zerr P; Horn A; Dees C; Akhmetshina A; Beyer C; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheum; 2011 Mar; 63(3):800-9. PubMed ID: 21360510
[TBL] [Abstract][Full Text] [Related]
12. B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis.
Hasegawa M; Hamaguchi Y; Yanaba K; Bouaziz JD; Uchida J; Fujimoto M; Matsushita T; Matsushita Y; Horikawa M; Komura K; Takehara K; Sato S; Tedder TF
Am J Pathol; 2006 Sep; 169(3):954-66. PubMed ID: 16936269
[TBL] [Abstract][Full Text] [Related]
13. The specific free radical scavenger edaravone suppresses fibrosis in the bleomycin-induced and tight skin mouse models of systemic sclerosis.
Yoshizaki A; Yanaba K; Ogawa A; Iwata Y; Ogawa F; Takenaka M; Shimizu K; Asano Y; Kadono T; Sato S
Arthritis Rheum; 2011 Oct; 63(10):3086-97. PubMed ID: 21618208
[TBL] [Abstract][Full Text] [Related]
14. The Role of TLR7 and TLR9 in the Pathogenesis of Systemic Sclerosis.
Wang C; Oishi K; Kobayashi T; Fujii K; Horii M; Fushida N; Kitano T; Maeda S; Ikawa Y; Komuro A; Hamaguchi Y; Matsushita T
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892317
[TBL] [Abstract][Full Text] [Related]
15. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease.
Ruzek MC; Jha S; Ledbetter S; Richards SM; Garman RD
Arthritis Rheum; 2004 Apr; 50(4):1319-31. PubMed ID: 15077316
[TBL] [Abstract][Full Text] [Related]
16. Animal models of scleroderma.
Lakos G; Takagawa S; Varga J
Methods Mol Med; 2004; 102():377-93. PubMed ID: 15286396
[TBL] [Abstract][Full Text] [Related]
17. A modified murine model of systemic sclerosis: bleomycin given by pump infusion induced skin and pulmonary inflammation and fibrosis.
Liang M; Lv J; Zou L; Yang W; Xiong Y; Chen X; Guan M; He R; Zou H
Lab Invest; 2015 Mar; 95(3):342-50. PubMed ID: 25502178
[TBL] [Abstract][Full Text] [Related]
18. Role of monocyte chemoattractant protein-1 and its receptor,CCR-2, in the pathogenesis of bleomycin-induced scleroderma.
Yamamoto T; Nishioka K
J Invest Dermatol; 2003 Sep; 121(3):510-6. PubMed ID: 12925209
[TBL] [Abstract][Full Text] [Related]
19. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse.
Komura K; Fujimoto M; Yanaba K; Matsushita T; Matsushita Y; Horikawa M; Ogawa F; Shimizu K; Hasegawa M; Takehara K; Sato S
Ann Rheum Dis; 2008 Jun; 67(6):867-72. PubMed ID: 17823201
[TBL] [Abstract][Full Text] [Related]
20. Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse.
Servettaz A; Goulvestre C; Kavian N; Nicco C; Guilpain P; Chéreau C; Vuiblet V; Guillevin L; Mouthon L; Weill B; Batteux F
J Immunol; 2009 May; 182(9):5855-64. PubMed ID: 19380834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
